Descriptor English: | Insulin, Lente | ||||
Descriptor Spanish: |
Insulina Lenta
| ||||
Descriptor Portuguese: | Insulina Lenta | ||||
Descriptor French: | Insuline lente | ||||
Entry term(s): |
Insulin Novo Monotard Insulin, Lente, Monocomponent Insulin, Monotard Lente Insulin Monotard Insulin Monotard, Insulin Novo Novo Monotard, Insulin |
||||
Tree number(s): |
D06.472.699.587.200.300.300 D12.644.548.586.200.300.300 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D061405 | ||||
Scope note: | An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage. |
||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Entry Combination: |
antagonists & inhibitors:Insulin Antagonists
|
||||
Pharm Action: |
Hypoglycemic Agents |
||||
Registry Number: | 8049-62-5 | ||||
Previous Indexing: |
Insulin, Long-Acting (1966-2011) |
||||
Public MeSH Note: | 2012; see INSULIN, LONG-ACTING 1966-2011; for INSULIN, LENTE, MONOCOMPONENT see INSULIN, LONG-ACTING 1983-2011; for INSULIN, MONTARD and INSULIN NOVO MONOTARD see INSULIN, LONG-ACTING 1984-2011 |
||||
History Note: | 2012; use INSULIN, LONG-ACTING 1966-2011; for INSULIN, LENTE, MONOCOMPONENT use INSULIN, LONG-ACTING 1983-2011; for INSULIN, MONTARD and INSULIN NOVO MONOTARD use INSULIN, LONG-ACTING 1984-2011 |
||||
DeCS ID: | 54561 | ||||
Unique ID: | D061405 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2012/01/01 | ||||
Date of Entry: | 2011/06/24 |
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Insulin, Lente
- Preferred
Insulin, Lente, Monocomponent
- Narrower
Insulin, Monotard
- Narrower
Insulin Novo Monotard
- Narrower
Concept UI |
M0011437 |
Scope note | An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage. |
Preferred term | Insulin, Lente |
Entry term(s) |
Lente Insulin |
Concept UI |
M0392725 |
Preferred term | Insulin, Lente, Monocomponent |
Concept UI |
M0392723 |
Preferred term | Insulin, Monotard |
Entry term(s) |
Monotard Insulin |
Concept UI |
M0392724 |
Preferred term | Insulin Novo Monotard |
Entry term(s) |
Monotard, Insulin Novo Novo Monotard, Insulin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey